To explore this possibility, we performed RNA-Seq on 17 patients with primary, untreated GBM from each MIF genotype in our Cleveland Clinic cohort who had similar clinical parameters and outcomes (Supplemental Table 2). The gene discussed is MIF; the disease is glioblastoma.